Type IV allergy to natural hirudin confirmed by in vitro stimulation with recombinant hirudin.
Zollner
T M
TM
Department of Dermatology, Universities of Frankfurt and Ulm, Germany.
Gall
H
H
Völpel
H
H
Kaufmann
R
R
D000991:Antithrombins / Q000009:adverse effects*; D016022:Case-Control Studies; D017449:Dermatitis, Allergic Contact / Q000175:diagnosis / Q000209:etiology*; D003875:Drug Eruptions / Q000175:diagnosis / Q000209:etiology*; D006629:Hirudins / Q000009:adverse effects*; D006801:Humans; D008213:Lymphocyte Activation; D008297:Male; D008875:Middle Aged; D009824:Ointments / Q000009:adverse effects
D000991:Antithrombins; D006629:Hirudins; D009824:Ointments